Riskpilot← Back to searchSign inGet full accessSista versen 89221 AB
ABDissolvedOrg 5592173057LundGeneral medical practice activities · NACE 8621Est. 20192 employees
Revenue 2024
SEK 939K
-66% vs 2023
EBITDA margin
-3.2%
-105% vs 2023
Equity ratio
98.0%
Financial strength
Net profit 2024
SEK -29K
-106% vs 2023
| Revenue | SEK 939K | -66% |
| EBITDA | SEK -30K | -105% |
| Net profit | SEK -29K | -106% |
| Total assets | SEK 491K | -71% |
| Equity | SEK 481K | -51% |
| Employees | 2 | — |
Legal name
Sista versen 89221 AB
Org number
5592173057
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
5 september 2019
Share capital
SEK 50 000
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanterna
Company purpose
Bolaget ska äga och förvalta fast och lös egendom och därmed förenlig verksamhet.
Address
Lund
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 817 | 1 307 | 2 082 | 2 803 | 939 |
| Staff expenses | — | — | −1 520 | −1 577 | −777 |
| EBITDA | 484 | 441 | 379 | 583 | −30 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 484 | 441 | 379 | 583 | −30 |
| Net financials | — | −1 | −0 | −0 | 1 |
| Profit before tax | 485 | 441 | 378 | 583 | −29 |
| Tax | −104 | −95 | −78 | −121 | — |
| Net profit | 381 | 346 | 300 | 462 | −29 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 661 | 913 | 955 | 1 667 | 491 |
| Equity | 431 | 599 | 716 | 990 | 481 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 230 | 314 | 239 | 677 | 10 |
| Total debt | 230 | 314 | 239 | 677 | 10 |
EBITDA margin
-3.2%
This company
15.8%
Market median
-120% vs market
20202024
Equity ratio
98.0%
This company
38.2%
Market median
+157% vs market
20202024
Return on equity
-6.0%
This company
18.4%
Market median
-133% vs market
20202024
Net profit margin
-3.1%
This company
8.1%
Market median
-138% vs market
20202024
Asset turnover
1.91×
This company
1.12×
Market median
+71% vs market
20202024
Debt / equity
0.02×
This company
0.62×
Market median
+97% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-09-01 – 2020-08-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
JZ Chief Executive Officer | Chief Executive Officer | 2022 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2025 | |
| Deputy Board Member | 2025 | |
| Board of Directors | 2025 | |
| Former (3) | ||
| Deputy Board Member | 2022 – 2025 | |
| Chairman | 2022 – 2025 | |
| Deputy Board Member | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Sista versen 89221 AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jenny Zhang | Chief Executive Officer | 0 companies |
| Nils Henrik Kristoffer Svensson | Deputy Board Member | 0 companies |
| Lina Anna Elisabeth Nordström | Deputy Board Member | 0 companies |
| Trung Kieu Ngo | Deputy Board Member | 0 companies |
| Karl-Johan Staffan Tångby | Board of Directors | 0 companies |
| Clara Nilsson | Chairman | 0 companies |
| Sandra Stella Nilsson | Deputy Board Member | 0 companies |